Assoc. Prof. ÇİĞDEM USUL AFŞAR


Tıp Fakültesi, Dahili Tıp Bilimleri

İç Hastalıkları


WoS Research Areas: Clinical Medicine (Med), Oncology, Clinical Medicine


Scopus Research Areas: Oncology


Avesis Research Areas: Medicine, Health Sciences, Internal Medicine Sciences, Internal Diseases, Oncology

Metrics

Publication

94

Publication (WoS)

46

Publication (Scopus)

37

Citation (WoS)

137

H-Index (WoS)

8

Citation (Scopus)

133

H-Index (Scopus)

7

Open Access

5
UN Sustainable Development Goals

Education

2010 - 2014

2010 - 2014

Post Doctorate of Medicine

Cukurova University, Tıp Fakültesi, İç Hastalıkları (Tıbbi Onkoloji), Turkey

2004 - 2010

2004 - 2010

Expertise In Medicine

Sbü İstanbul Eğitim Ve Araştırma Hastanesi, İç Hastalıkları, İç Hastalıkları, Turkey

2002 - 2004

2002 - 2004

Postgraduate

İstanbul University-Cerrahpaşa, Tıp Fakültesi, Farmakoloji, Turkey

1995 - 2001

1995 - 2001

Undergraduate

İstanbul University-Cerrahpaşa, Tıp Fakültesi, Turkey

Foreign Languages

C1 Advanced

C1 Advanced

English

Research Areas

Medicine

Health Sciences

Internal Medicine Sciences

Internal Diseases

Oncology

Research Areas Based on Academic Activities

Avesis Research Areas

    WoS Research Areas

      Scopus Research Areas

        Non Academic Experience

        2023 - Continues

        2023 - Continues

        Tıbbi Onkoloji Eğitim ve İdari Sorumlusu

        İSTANBUL EĞİTİM VE ARAŞTIRMA HASTANESİ, Tıbbi Onkoloji Eğitim ve İdari Sorumlusu

        2010 - 2011

        2010 - 2011

        İç Hastalıkları Uzmanı

        Esenyurt Devlet Hastanesi, İç Hastalıkları Uzmanı

        Articles

        All (55)
        SCI-E, SSCI, AHCI (30)
        SCI-E, SSCI, AHCI, ESCI (39)
        ESCI (9)
        Scopus (37)
        TRDizin (13)
        Other Publications (10)

        Papers Presented at Peer-Reviewed Scientific Conferences

        2019

        2019

        2. Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study

        Karabulut S., DOĞAN İ., AK N., Afsar C. U., KARABULUT M., Tastekin D.

        44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.305, (Summary Text) Sustainable Development identifier

        2016

        2016

        3. The blood neutrophil/lymphocyte ratio in breast cancer

        KORO A., ARAL H., GURSU R. U., TRABULUS D. C., NAZLI M. A., Afsar C. U., et al.

        41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.256-257, (Summary Text) Sustainable Development identifier

        2016

        2016

        4. Diagnostic and prognostic roles of serum interleukin-32 (IL-32) levels in patients with pancreatic adenocarcinoma.

        KARABULUT S., Afsar C. U., YASASEVER V., KARABULUT M., ERTURK K., ALIS H., et al.

        Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34, (Summary Text) identifier

        2015

        2015

        5. The effect of platinum and docetaxel based chemoradiotherapy on survival in locally advanced unresectable non-small cell lung cancer patients.

        AFSAR C. U., GUNALDI M., KARACA F., Kara I. O., Sahin B., DUMAN B. B., et al.

        Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text) Sustainable Development identifier

        2015

        2015

        7. Can Heat Shock Protein 70 be a Target Therapy in Breast Cancer

        GÜNALDI m., USUL AFŞAR Ç., OKUTURLAR y., GEDİKBAŞI a., ALEV k., GÜNDÜZ u.

        International Symposium on Advances In Predictive and Personalized Medicine, 2 - 03 April 2015 Sustainable Development

        2015

        2015

        8. Paraoxonase and Arylesterase Activities in Patients with Coloractal Cancer

        USUL AFŞAR Ç., meral g., yıldız o., asuman g., alev k.

        International Symposium on Advances In Predictive And Personalized Medicine, 2 - 03 April 2015 Sustainable Development

        2014

        2014

        11. The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.

        GUNALDI M., ERKISI M., AFSAR C. U., ERCOLAK V., Paydas S., Kara I. O., et al.

        50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32, (Summary Text) Sustainable Development identifier

        2013

        2013

        12. Özafagus Kanserli 64 Hasta

        USUL AFŞAR Ç., ŞAHİN B., KARA İ. O., MERAL g., BERNA b. d., KUM p., et al.

        10. Ulusal Tıbbi Onkoloji Kongresi., Turkey, 11 - 15 September 2013 Sustainable Development

        2013

        2013

        13. Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer.

        Duman B. B., Gunaldi M., Tasdogan B. E., Afsar C. U., Paydas S., Gumurdulu Y.

        Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text) Sustainable Development identifier

        2012

        2012

        16. Akromegaliye Eşlik Eden Malign Mezankimal Tümör

        MERAL g., KARA İ. O., USUL AFŞAR Ç., ERÇOLAK V., BERNA b. d.

        9. Ulusal Tıbbi Onkoloji Kongresi, Turkey, 12 - 16 September 2012

        2012

        2012

        17. Sorafenib in the treatment of metastatic paraganglioma: A case report.

        Gunaldi M., Kara I. O., Afsar C. U., Duman B. B.

        48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30, (Summary Text) identifier

        2012

        2012

        26. Erişkin Wilms Tümörü

        ERÇOLAK V., KARA İ. O., USUL AFŞAR Ç., MERAL g., ERDOĞAN Ş., BERNA t. a.

        4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

        2012

        2012

        32. Richter sendromu

        MERAL g., KÖKSAL ERKİŞİ M., USUL AFŞAR Ç., BERNA b. d., ERÇOLAK v.

        4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

        2012

        2012

        34. Muir Torre Sendromu

        USUL AFŞAR Ç., KARA İ. O., MERAL g., BERNA b. d., ERÇOLAK V., PARSAK C. K., et al.

        4. Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2012

        Books

        2019

        2019

        1. Novel Strategies and Approaches in Hypertension Therapy

        USUL AFŞAR Ç., ÖZYAZGAN S.

        in: Bentham Books, , Editor, Bentham Science Publishers, 2019

        2014

        2014

        2. Yüksek Dereceli Gliomlarda Etyoloji ve Risk Faktörleri

        USUL AFŞAR Ç., ŞAHİN B.

        in: Klinik Tıp Bilimleri, Ömür Günaldı, Editor, Selen Yayıncılık, 2014

        Activities in Scientific Journals

        2019 - Continues

        2019 - Continues

        CPQ CancerSustainable Development

        Committee Member

        2019 - Continues

        2019 - Continues

        Eurasian Journal of Clinical Investigation

        Committee Member

        Memberships and Roles in Scientific Organizations

        2019 - Continues

        2019 - Continues

        Interdisipliner Onkoloji Derneği (IDOD)

        Board Member

        2019 - Continues

        2019 - Continues

        Türk Tıbbi Onkoloji Derneği

        Member

        2017 - Continues

        2017 - Continues

        Türk Tabipler Birliği

        Member

        2014 - Continues

        2014 - Continues

        ESMO (European Society of Medical Oncology)

        Member

        

        Congress and Symposium Activities

        01 December 2019 - 01 December 2019

        01 December 2019 - 01 December 2019

        9th INTERNATIONAL GASTROINTESTINAL CANCER CONFERENCESustainable Development

        Attendee

        İstanbul-Turkey

        01 November 2019 - 01 November 2019

        01 November 2019 - 01 November 2019

        6th MEDMOF AND 3rd ICONS

        Attendee

        Antalya-Turkey

        01 October 2019 - 01 October 2019

        01 October 2019 - 01 October 2019

        XTH EURASİAN HEMATOLOGY ONCOLOGY CONGRESS

        Attendee

        İstanbul-Turkey

        Citations

        Total Citations (WOS): 135

        h-index (WOS): 8